Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view.

Tytuł:: Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view.
Autorzy:: Huart C; Department of Otorhinolaryngology, Cliniques universitaires Saint-Luc, Brussels, Belgium.; Institute of Neuroscience, Univeristé catholique de Louvain, Brussels, Belgium.
Philpott CM; The Norfolk Smell and Taste Clinic, Norfolk and Waveney ENT Service, Gorleston, UK.; Norwich Medical School, University of East Anglia, Norwich, UK.
Altundag A; Department of Otorhinolaryngology, Biruni University, Istanbul, Turkey.
Fjaeldstad AW; Flavour Clinic, Department of Otorhinolaryngology, Regional Hospital West Jutland, Holstebro, Denmark.; Flavour Institute, Aarhus University, Aarhus, Denmark.
Frasnelli J; Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada.
Gane S; Department of Rhinology, Royal National ENT Hospital, University College London Hospitals NHS Foundation Trust, London, UK.; UCL Ear Institute, University College London, London, UK.
Hsieh JW; Department of Otorhinolaryngology-Head and Neck Surgery, Rhinology-Olfactory Unit, Geneva University Hospitals, Geneva, Switzerland.
Holbrook EH; Massachusetts Eye and Ear, Harvard University, Boston, Massachusetts.
Konstantinidis I; 2nd Academic ORL Department, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece.
Landis BN; Department of Otorhinolaryngology-Head and Neck Surgery, Rhinology-Olfactory Unit, Geneva University Hospitals, Geneva, Switzerland.
Macchi A; ENT clinic Asst-Settelaghi-University of Insubriae, Varese, Italy.
Mueller CA; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Negoias S; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Basel, CH-4051, Basel, Switzerland.
Pinto JM; Section of Otolaryngology-Head and Neck Surgery, The University of Chicago, Chicago, Illinois.
Poletti SC; Department of Otorhinolaryngology, Inselspital University Hospital Bern, Bern, Switzerland.
Ramakrishnan VR; Department of Otolaryngology-Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Rombaux P; Department of Otorhinolaryngology, Cliniques universitaires Saint-Luc, Brussels, Belgium.; Institute of Neuroscience, Univeristé catholique de Louvain, Brussels, Belgium.
Vodicka J; Department of Otorhinolaryngology and Head and Neck Surgery, Hospital of Pardubice, Pardubice, Czech Republic.
Welge-Lüessen A; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Basel, CH-4051, Basel, Switzerland.
Whitcroft KL; UCL Ear Institute, University College London, London, UK.; The Centre for Olfactory Research and Applications, Institute of Philosophy, School of Advanced Study, London, UK.
Hummel T; Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany.
Źródło:: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2021 Jul; Vol. 11 (7), pp. 1041-1046. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Hoboken : Published for ARS-AAOA by Wiley-Blackwell
MeSH Terms:: COVID-19*/complications
COVID-19*/physiopathology
Olfaction Disorders*/drug therapy
Olfaction Disorders*/epidemiology
Olfaction Disorders*/etiology
Adrenal Cortex Hormones/*pharmacology
Medication Therapy Management/*statistics & numerical data
Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/etiology ; Drug-Related Side Effects and Adverse Reactions/prevention & control ; Global Health ; Humans ; Medication Therapy Management/standards ; Needs Assessment ; Olfactory Mucosa/drug effects ; Olfactory Mucosa/virology ; Remission, Spontaneous ; Research Design ; SARS-CoV-2/pathogenicity
References:: N Engl J Med. 2021 Feb 25;384(8):693-704. (PMID: 32678530)
Rhinology. 2020 Feb 20;58(Suppl S29):1-464. (PMID: 32077450)
Laryngoscope. 2012 Apr;122(4):747-50. (PMID: 22302665)
Ann Otol Rhinol Laryngol. 2021 May;130(5):513-519. (PMID: 33025798)
Eur Arch Otorhinolaryngol. 2016 Apr;273(4):939-43. (PMID: 26141752)
Curr Allergy Asthma Rep. 2020 Oct 13;20(12):76. (PMID: 33048282)
Laryngoscope. 2018 Jan;128(1):10-15. (PMID: 28556265)
Chem Senses. 2020 Dec 5;45(9):875-881. (PMID: 33033827)
Neural Regen Res. 2018 Oct;13(10):1711-1714. (PMID: 30136681)
Clin Otolaryngol. 2021 Jan;46(1):16-22. (PMID: 32854169)
Eur J Neurol. 2020 Nov;27(11):2318-2321. (PMID: 32677329)
Physiol Rep. 2020 Sep;8(18):e14578. (PMID: 32975884)
Eur Arch Otorhinolaryngol. 2021 Jan 9;:. (PMID: 33423106)
Int Forum Allergy Rhinol. 2021 Jul;11(7):1041-1046. (PMID: 33728824)
Acta Otolaryngol. 2020 Dec;140(12):1032-1035. (PMID: 32852240)
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950. (PMID: 32301284)
Int Forum Allergy Rhinol. 2018 Sep;8(9):977-981. (PMID: 29901865)
Dan Med J. 2020 Aug 1;67(8):. (PMID: 32741438)
Laryngoscope. 2004 Oct;114(10):1764-9. (PMID: 15454769)
Int Forum Allergy Rhinol. 2019 Feb;9(2):165-176. (PMID: 30472771)
Indian J Otolaryngol Head Neck Surg. 2020 Oct 14;:1-6. (PMID: 33078125)
Otolaryngol Head Neck Surg. 2021 Mar;164(3):512-518. (PMID: 32867582)
Epilepsia. 2020 Aug;61(8):e90-e94. (PMID: 32589794)
Rhinology. 1994 Sep;32(3):113-8. (PMID: 7530857)
Laryngoscope. 2020 Nov;130(11):2680-2685. (PMID: 32794209)
Otolaryngol Head Neck Surg. 2020 Dec;163(6):1144-1149. (PMID: 32600175)
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2363-2369. (PMID: 33385250)
J Laryngol Otol. 2020 Aug;134(8):703-709. (PMID: 32782030)
Philos Trans R Soc Lond B Biol Sci. 2020 Jun 8;375(1800):20190265. (PMID: 32306872)
Neurology. 2019 Aug 27;93(9):e841-e850. (PMID: 31358617)
J Intern Med. 2021 Jan 5;:. (PMID: 33403772)
Am J Otolaryngol. 2020 Nov - Dec;41(6):102725. (PMID: 32979666)
Am J Otolaryngol. 2020 Nov - Dec;41(6):102639. (PMID: 32682192)
Case Rep Otolaryngol. 2020 Aug 8;2020:5892047. (PMID: 32802540)
Cochrane Database Syst Rev. 2013 Jul 02;(7):CD003998. (PMID: 23818120)
Int Forum Allergy Rhinol. 2020 Sep;10(9):1065-1086. (PMID: 32567798)
Eur Arch Otorhinolaryngol. 2021 Jan;278(1):101-108. (PMID: 32754871)
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831. (PMID: 32329222)
Acta Otolaryngol. 2012 Jun;132 Suppl 1:S27-31. (PMID: 22582778)
Rhinol Suppl. 2017 Mar;54(26):1-30. (PMID: 29528615)
Int Forum Allergy Rhinol. 2021 May;11(5):837-845. (PMID: 32970395)
Allergy. 2021 Mar;76(3):677-688. (PMID: 33075144)
Contributed Indexing:: Keywords: COVID-19; SARS-CoV-2; corticosteroids; olfaction disorder; smell
Substance Nomenclature:: 0 (Adrenal Cortex Hormones)
Entry Date(s):: Date Created: 20210317 Date Completed: 20210706 Latest Revision: 20210706
Update Code:: 20240105
PubMed Central ID:: PMC8251281
DOI:: 10.1002/alr.22788
PMID:: 33728824
: Czasopismo naukowe

Pełny tekst

The frequent association between coronavirus disease 2019 (COVID-19) and olfactory dysfunction is creating an unprecedented demand for a treatment of the olfactory loss. Systemic corticosteroids have been considered as a therapeutic option. However, based on current literature, we call for caution using these treatments in early COVID-19-related olfactory dysfunction because: (1) evidence supporting their usefulness is weak; (2) the rate of spontaneous recovery of COVID-19-related olfactory dysfunction is high; and (3) corticosteroids have well-known potential adverse effects. We encourage randomized placebo-controlled trials investigating the efficacy of systemic steroids in this indication and strongly emphasize to initially consider smell training, which is supported by a robust evidence base and has no known side effects.
(© 2021 ARS-AAOA, LLC.)

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja